Cellectis SA
NASDAQ:CLLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cellectis SA
NASDAQ:CLLS
|
FR |
|
F
|
Fufeng Group Ltd
XMUN:FFO1
|
CN |
|
S
|
Sleep Country Canada Holdings Inc
OTC:SCCAF
|
CA |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
C
|
Coal India Ltd
BSE:533278
|
IN |
|
C
|
Country Garden Services Holdings Co Ltd
OTC:CTRGF
|
CN |
|
Q
|
Qiagen NV
XMUN:QIA
|
NL |
|
Oncozenge AB
F:8LY
|
SE |
Wall St Price Targets
CLLS Price Targets Summary
Cellectis SA
According to Wall Street analysts, the average 1-year price target for CLLS is 7.84 USD with a low forecast of 7.76 USD and a high forecast of 8.07 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLLS's stock price target?
Price Target
7.84
USD
According to Wall Street analysts, the average 1-year price target for CLLS is 7.84 USD with a low forecast of 7.76 USD and a high forecast of 8.07 USD.
What is the Revenue forecast for Cellectis SA?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 7 years is 21%.
What is the Gross Profit forecast for Cellectis SA?
Projected CAGR
162%
The compound annual growth rate for Gross Profit over the next 1 year is 162%.
